Clinical Trial

MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

Study acronym: ANO5 MRI
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-13
notable Primary completion pushed: 2026-02-01 -> 2026-06-01 2026-08-13
Trial Details
NCT Number NCT05102799
Lead Sponsor Rigshospitalet, Denmark
Conditions Limb Girdle Muscular Dystrophy
Enrollment 200 participants
Start Date 2021-04-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12